Get the Stockscreener App
1.15
1.71%
-0.02
After Hours:
1.15
Calidi Biotherapeutics Inc stock is traded at $1.15, with a volume of 23,553.
It is down -1.71% in the last 24 hours and down -21.23% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.17
Open:
$1.17
24h Volume:
23,553
Relative Volume:
0.16
Market Cap:
$8.24M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-1.5608
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-21.23%
6M Performance:
-61.01%
1Y Performance:
-92.33%
1-Day Range:
$1.15
$1.18
1-Week Range:
$1.1203
$1.22
52-Week Range:
$1.10
$19.20
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.15 | 8.39M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Will Calidi Biotherapeutics Inc. stock issue positive guidance2026 world cup usa national team third place match playmakers pressing system group prediction tactical review - Улправда
Calidi Biotherapeutics sinks after pricing $3.9M registered direct offering - MSN
Will Calidi Biotherapeutics Inc. stock outperform international peersEarnings Miss Alerts & Affordable Trading Portfolio - bollywoodhelpline.com
Retail Surge: Will Calidi Biotherapeutics Inc stock outperform international peersJuly 2025 Drop Watch & Fast Gain Swing Trade Alerts - moha.gov.vn
Is Calidi Biotherapeutics Inc. stock positioned for long term growthDebt-to-Equity Ratio Analysis & Free Unlock Rapid Growth Potential - Bollywood Helpline
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Calidi Biotherapeutics Earnings Notes - Trefis
How sustainable is Calidi Biotherapeutics Inc. stock dividend payout2025 Technical Patterns & Low Risk High Reward Ideas - DonanımHaber
Bearish Setup: How risky is Calidi Biotherapeutics Inc. stock nowGlobal Markets & Safe Entry Zone Identification - Улправда
Is Calidi Biotherapeutics Inc. stock a smart buy before Fed meeting2025 Support & Resistance & Free Daily Entry Point Trade Alerts - DonanımHaber
Is Calidi Biotherapeutics Inc. stock inflation resilientJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - DonanımHaber
Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Aug Weekly: How risky is Calidi Biotherapeutics Inc. stock nowJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - Улправда
Rally Mode: How risky is Calidi Biotherapeutics Inc. stock nowDollar Strength & Real-Time Sentiment Analysis - Улправда
Calidi Biotherapeutics (CLDI) director details estate-planning share sale - Stock Titan
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Cape Cod Times
Why retail investors favor Calidi Biotherapeutics Inc. stockQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
Why Calidi Biotherapeutics Inc. stock stays on top picksOil Prices & Free Technical Confirmation Trade Alerts - Newser
Will Calidi Biotherapeutics Inc. stock outperform benchmarksQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Will Calidi Biotherapeutics Inc. stock outperform small cap peersPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Will Calidi Biotherapeutics Inc. stock rally after Fed decisions2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Is Calidi Biotherapeutics Inc. stock supported by strong fundamentals2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
How analysts revise price targets for Calidi Biotherapeutics Inc. stockTrade Exit Summary & Safe Capital Investment Plans - Newser
Will Calidi Biotherapeutics Inc. stock split increase liquidityShare Buyback & Growth Focused Stock Reports - Newser
Day Trade: Will Calidi Biotherapeutics Inc. stock outperform international peersJuly 2025 Chart Watch & Accurate Intraday Trade Tips - moha.gov.vn
Is Calidi Biotherapeutics Inc. stock undervalued vs historical averagesEarnings Overview Report & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Calidi Biotherapeutics, Inc. (CLDI) -6.8% in After-hours: Shares Decline Amid Routine Market Activity - Stocks Telegraph
Calidi Biotherapeutics Inc. (CLDI) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
What margin trends mean for Calidi Biotherapeutics Inc. stockMarket Growth Summary & Daily Chart Pattern Signals - newser.com
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Calidi Biotherapeutics Inc Stock (CLDI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schoeneck James A | Director |
Aug 21 '25 |
Buy |
2.00 |
75,000 |
150,000 |
76,134 |
| Poma Eric E | Chief Executive Officer |
Aug 21 '25 |
Buy |
2.00 |
25,000 |
50,000 |
25,000 |
| Leftwich Scott | Director |
Aug 21 '25 |
Buy |
2.00 |
125,000 |
250,000 |
130,650 |
| Jackson Andrew C. | Chief Financial Officer |
Aug 21 '25 |
Buy |
2.00 |
2,500 |
5,000 |
2,500 |
2.52%
0.07%
Cap:
|
Volume (24h):